Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy

Pain, Postoperative Clinical Trial

Official title:

Effect of Perioperative Electroacupuncture With Tramadol and Ketamine on Postoperative Analgesia in Prostatectomy: a Randomized Placebo-controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01526525
• Other study ID #: 6151/ 22-7-2009
• Status: Completed
• Phase: Phase 4
• First received: January 28, 2012
• Last updated: February 20, 2014
• Start date: July 2009
• Est. completion date: February 2012

Study information

• Verified date: February 2014
• Source: G.Gennimatas General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Greece: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

The aim of the present study is the comparison of the efficacy of the perioperative application of a multimodal analgesia model to the patients, combing common used analgesics via intravenous (IV) route, such as tramadol and ketamine, with or without the Electroacupuncture (E/A) technique application and the frequency of side effects accession.

Description:

Seventy patients were scheduled for radical prostatectomy, were recruited to this prospective single-blind, were randomized and placebo-controlled by trial. They were randomly divided into two groups of 35 patients each by a computer-generated randomization sequence, the TKE (Tramadol + Ketamine + Electroacupuncture), and TK (Tramadol + Ketamine + placebo Electroacupuncture.The randomization performed by the certified acupuncturist.

Patients were anesthetized with the same protocol by five anesthesiologists, who were not involved in the postoperative assessment of the patients, but were aware in which group acupuncture was used and in which not. Both groups, TKE and TK, were administered tramadol 1.5mg/kg and ketamine 10mg bolus IV 30min before the end of the surgery and co instantaneously the CIV infusion of tramadol 0.15mg/kg/h and ketamine, in subanesthetic doses, 0.15mg/kg/h started with continuous infusion in an adjustable flow disposable pump (paragon®).Ketamine's dose was altered so as not to exceed the 300mg/24h. An hour before the end of the surgery all patients were administered with parecoxib 40mg (IV) and 30min before paracetamol 20mg/kg (IV).

In TKE group when the closure of the abdominal walls started, a certified acupuncturist expert put needles, Ener-Qi 0.26Χ25mms, in LI4 point at 2cm depth in both hands and E/A was applied for 30min with the E/A stimulator ITO ES-160 in constant pulse program with 300μs duration and 100Hz frequency. After the needles were connected to the E/A stimulator, they were secured by adhesive tape. The response which certified the right needle placement was the adjacent muscular twitch. Thereafter the electroacupuncture machine was deactivated and after the awakening of the patients, E/A was administered in ST36 and LI4 points for 30min with 4Hz frequency. The electrodes were connected to each other in every point, as the right with the left point of LI4 and the right with the left point of ST36. In the TK group the needles were not inserted in the skin but they were put atop the skin and were secured by adhesive tape, the indicator light was on but no electrical current was applied. The patients were told that they may or may not feel electrical current because of its very high frequency.

The study was single blind as patients although they were informed for the Electroacupuncture (E/A) technique during the first session they were anesthetized and the second one was after the awakening of anesthesia and they didn't understand it. On the other hand anaesthesiologists and the certified acupuncturist during the EAc application knew in which group patients belong although they did not deal with them postoperatively. However, patient assessments were performed at standard time points as 45 min in recovery and at 2 h, 6 h, 12 h and 24 h after surgery in the ward by another anaesthesiologist who was not present during the surgery or the recovery room for the first 30 min.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: February 2012
• Est. primary completion date: September 2011
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 50 Years to 75 Years

Eligibility

Inclusion Criteria:

• Male patient is over 18 years old, especially 50-75 years old

• Patient scheduled for a non-emergency operation

• Patient signs and dates a written informed consent form (ICF) and indicates an understanding of the study procedures

Exclusion Criteria:

• Patient receiving monoamine oxidase inhibitors and selective serotonin reuptake inhibitors

• Patient with significant cardiovascular, pulmonary, renal or hepatic disease

• Patient with epilepsy non controlled with treatment or history of seizures

• Patient with morbid obesity (BMI>35)

• Patient with history of chronic opioid exposure

• Patient with history of chronic pain

• Patient with history of postoperative nausea and vomiting

• Patient with cognitive dysfunction

• Patient with history of previous usage of the acupuncture technique

• Patient Greek speaking

• Patient is participating in another clinical trial which may affect this study's outcomes

• Patient with metastatic cancer

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pain, Postoperative

Intervention

Drug:
• Tramadol
Tramadol 1.5mg/kg bolus IV 30min before the end of the surgery and co instantaneously the CIV infusion of tramadol 0.15mg/kg/h started with continuous infusion in an adjustable flow disposable pump (paragon®)
• Ketamine
ketamine 10mg bolus IV 30min before the end of the surgery and co instantaneously the CIV infusion of ketamine, in subanesthetic doses, 0,15mg/kg/h started with continuous infusion in an adjustable flow disposable pump (paragon®). Ketamine's dose was altered so as not to exceed the 300mg/24h.
• Tramadol
If NRS scale was =3, PPI scale =2 and the algometer count =0,5Kg it was assumed as a non acceptable pain treatment. Tramadol 50mg IV bolus was firstly administered to the patients.The aim was that the Tramadol 24h dose would not exceed 600mg
• Morphine
If NRS scale was =3, PPI scale =2 and the algometer count =0,5Kg it was assumed as a non acceptable pain treatment. Tramadol 50mg IV bolus was firstly administered to the patients and if the NRS scale was not decreased at least about 2 points after 30 minutes, morphine 2mg IV was then administered and it could be repeated

Procedure:
• sedation
If the patient had sedation score >2 then the analgesic infusion would be stopped, the patient would be assessed again in 1 hour and the infusion would start with the same or decreased flow.
• rescue analgesia
Meanwhile - 45min,2h,6h,12h and 24h- if the patients had acute pain, the physician would call the anesthesiologist and a new assessment would take place with the relative interventions.

Drug:
• Parecoxib
An hour before the end of the surgery all patients were administered with parecoxib 40mg (IV)
• paracetamol
30min before the end of the surgery paracetamol 20mg/kg (IV).

Locations

Country	Name	City	State
Greece	G.Gennimatas GENERAL HOSPITAL OF THESSALONIKI	Thessaloniki

Sponsors (2)

Lead Sponsor	Collaborator
G.Gennimatas General Hospital	Aristotle University Of Thessaloniki

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PAIN SCALES	Numerical Rating Scale (NRS) 0-10,from 0=no pain to 10=worst pain imaginable. Present Pain Intensity (PPI) 0-5,from 0= no pain to 5= excruciating. McGill pain scale (SF-MPQ) 0-3,from 0=no pain to 3=severe pain	45min, 2h, 6h, 12h and 24h following the surgery	Yes
Primary	PATIENTS PAIN THRESHOLD WITH ELECTRONIC PRESSURE ALGOMETER	The electronic pressure algometer device was applied 2cm bilateral the middle of the midline extraperitoneal lower abdominal incision and were recorded the pain threshold. It converted in Kg	45min, 2h, 6h, 12h and 24h following the surgery	Yes
Primary	NUMBER OF PARTICIPANTS WITH ADVERSE EVENTS	Nausea:yes/no vomiting:yes/no pruritus:yes/no bowel movement:yes/no Sedation scale 0-3, from 0= awake or sleepy that answers to the questions to 3=asleep who doesn't awake not even with a prod	45min, 2h, 6h, 12h and 24h following the surgery	Yes
Primary	PATIENTS RESCUE ANALGESIA	If NRS scale was =3, PPI scale =2 and the algometer count =0,5Kg it was assumed as a non acceptable pain treatment. Tramadol 50mg IV bolus was firstly administered to the patients and if the NRS scale was not decreased at least about 2 points after 30 minutes, morphine 2mg IV was then administered and it could be repeated. The aim was that the Tramadol 24h dose would not exceed 600mg. So with rescue analgesia, tramadol or morphine in mg, we count the total amount of opioids administered	45min, 2h, 6h,12h and 24h following the surgery	Yes
Primary	CORTIZOL	Cortizol levels: ug/dl	: 1st at 8am at the day of the surgery (Cort1), 2nd 45min after the end of the surgery (Cort2) and 3rd at 8am the first postoperative day (Cort3)	Yes
Secondary	PATIENTS WELLBEING,	Spielberger State Trait Anxiety Inventory (STAI Y-6 item) 1-4, where 1=not at all and 4 =very much so.	Preoperatively and 24h following the surgery	Yes
Secondary	SATISFACTION	Verbal Rating Scale (VRS) with 6 levels of satisfaction 1-6,from 1=very dissatisfied to 6= very satisfied	24h following the surgery	Yes
Secondary	SLEEP DISORDERS	Answer to questions such as "if they slept well?" yes/no "they had nightmares or bad dreams?" yes/no	24h following the surgery	Yes